Vimian Group AB (publ) (VIMGF)

OTCMKTS · Delayed Price · Currency is USD
4.300
0.00 (0.00%)
At close: Jul 14, 2025
Market Cap1.84B
Revenue (ttm)474.81M
Net Income (ttm)26.78M
Shares Outn/a
EPS (ttm)0.05
PE Ratio68.83
Forward PE27.30
Dividendn/a
Ex-Dividend Daten/a
Volume4,000
Average Volume5,930
Open4.300
Previous Closen/a
Day's Range4.300 - 4.300
52-Week Range3.150 - 4.500
Beta1.53
RSI51.69
Earnings DateJul 18, 2025

About Vimian Group AB

Vimian Group AB (publ) engages in the animal health business worldwide. It operates through Specialty Pharma, MedTech, Diagnostics, and Veterinary Services segments. The company offers proprietary diagnostics, prescription, and non-prescription treatments for preventive care and treatment of chronic conditions for companion animals under the Nextmune brand name; and molecular and immunodiagnostic solutions that are used by laboratories for veterinary specific applications with a focus on livestock and companion animal health markets under the I... [Read more]

Sector Healthcare
Founded 2020
Employees 1,200
Stock Exchange OTCMKTS
Ticker Symbol VIMGF
Full Company Profile

Financial Performance

In 2024, Vimian Group AB's revenue was 374.80 million, an increase of 12.99% compared to the previous year's 331.70 million. Earnings were 18.50 million, an increase of 88.78%.

Financial numbers in EUR Financial Statements

News

There is no news available yet.